% alzhub.org library filter
% Source: https://alzhub.org/research?atag=repurposing
% 234 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{hua2022-35180125,
  author  = {Hua, Xue and Church, Kevin and Walker, William and L'Hostis, Philippe and Viardot, Geoffrey and Danjou, Philippe and Hendrix, Suzanne and Moebius, Hans J},
  title   = {{Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2022},
  doi     = {10.3233/jad-215511},
  pmid    = {35180125},
  url     = {https://doi.org/10.3233/jad-215511}
}

@article{wang2020-32928279,
  author  = {Wang, Tao and Kuang, Weihong and Chen, Wei and Xu, Wenwei and Zhang, Liming and Li, Yingjie and Li, Hailin and Peng, Ying and others},
  title   = {{A phase II randomized trial of sodium oligomannate in Alzheimer's dementia}},
  journal = {Alzheimer's research \& therapy},
  year    = {2020},
  doi     = {10.1186/s13195-020-00678-3},
  pmid    = {32928279},
  url     = {https://doi.org/10.1186/s13195-020-00678-3}
}

@article{nordberg2009-19199870,
  author  = {Nordberg, Agneta and Darreh-Shori, Taher and Peskind, Elaine and Soininen, Hilkka and Mousavi, Malahat and Eagle, Gina and Lane, Roger},
  title   = {{Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients}},
  journal = {Current Alzheimer research},
  year    = {2009},
  doi     = {10.2174/156720509787313961},
  pmid    = {19199870},
  url     = {https://doi.org/10.2174/156720509787313961}
}

@article{faux2010-20164561,
  author  = {Faux, N. G. and Ritchie, C. W. and Gunn, A. and Rembach, A. and Tsatsanis, A. and Bedo, J. and Harrison, J. and Lannfelt, L. and others},
  title   = {{PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2010},
  doi     = {10.3233/jad-2010-1390},
  pmid    = {20164561},
  url     = {https://doi.org/10.3233/jad-2010-1390}
}

@article{jang2022-36440278,
  author  = {Jang, Ha Young and Oh, Jung Mi and Kim, In-Wha},
  title   = {{Drug repurposing using meta-analysis of gene expression in Alzheimer's disease}},
  journal = {Frontiers in neuroscience},
  year    = {2022},
  doi     = {10.3389/fnins.2022.989174},
  pmid    = {36440278},
  url     = {https://doi.org/10.3389/fnins.2022.989174}
}

@article{bourdakou2023-37696195,
  author  = {Bourdakou, Marilena M and Fernández-Ginés, Raquel and Cuadrado, Antonio and Spyrou, George M},
  title   = {{Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood}},
  journal = {Redox biology},
  year    = {2023},
  doi     = {10.1016/j.redox.2023.102881},
  pmid    = {37696195},
  url     = {https://doi.org/10.1016/j.redox.2023.102881}
}

@article{vanderoovaart2023-38004378,
  author  = {Van de Roovaart, Hannah J and Nguyen, Nguyen and Veenstra, Timothy D},
  title   = {{Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis}},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  year    = {2023},
  doi     = {10.3390/ph16111513},
  pmid    = {38004378},
  url     = {https://doi.org/10.3390/ph16111513}
}

@article{flicker1994-8267111,
  author  = {Flicker, C and Ferris, S H and Kalkstein, D and Serby, M},
  title   = {{A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease}},
  journal = {The American journal of psychiatry},
  year    = {1994},
  doi     = {10.1176/ajp.151.1.126},
  pmid    = {8267111},
  url     = {https://doi.org/10.1176/ajp.151.1.126}
}

@article{fonsecasantos2015-26345528,
  author  = {Fonseca-Santos, B. and Gremião, M. P. and Chorilli, M.},
  title   = {{Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease}},
  journal = {International journal of nanomedicine},
  year    = {2015},
  doi     = {10.2147/ijn.s87148},
  pmid    = {26345528},
  url     = {https://doi.org/10.2147/ijn.s87148}
}

@article{prvulovic2010-20113148,
  author  = {Prvulovic, David and Hampel, Harald and Pantel, Johannes},
  title   = {{Galantamine for Alzheimer's disease}},
  journal = {Expert opinion on drug metabolism \& toxicology},
  year    = {2010},
  doi     = {10.1517/17425251003592137},
  pmid    = {20113148},
  url     = {https://doi.org/10.1517/17425251003592137}
}

@article{dunbar2007-17225162,
  author  = {Dunbar, G. and Boeijinga, P. H. and Demazières, A. and Cisterni, C. and Kuchibhatla, R. and Wesnes, K. and Luthringer, R.},
  title   = {{Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers}},
  journal = {Psychopharmacology},
  year    = {2007},
  doi     = {10.1007/s00213-006-0675-x},
  pmid    = {17225162},
  url     = {https://doi.org/10.1007/s00213-006-0675-x}
}

@article{robinson2006-16906789,
  author  = {Robinson, D. M. and Keating, G. M.},
  title   = {{Memantine: a review of its use in Alzheimer's disease}},
  journal = {Drugs},
  year    = {2006},
  doi     = {10.2165/00003495-200666110-00015},
  pmid    = {16906789},
  url     = {https://doi.org/10.2165/00003495-200666110-00015}
}

@article{corbett2012-23123941,
  author  = {Corbett, A. and Pickett, J. and Burns, A. and Corcoran, J. and Dunnett, S. B. and Edison, P. and Hagan, J. J. and Holmes, C. and others},
  title   = {{Drug repositioning for Alzheimer's disease}},
  journal = {Nature reviews. Drug discovery},
  year    = {2012},
  doi     = {10.1038/nrd3869},
  pmid    = {23123941},
  url     = {https://doi.org/10.1038/nrd3869}
}

@article{frost2024-39766362,
  author  = {Frost, Emma D and Shi, Swanny X and Byroju, Vishnu V and Rissardo, Jamir Pitton and Donlon, Jack and Vigilante, Nicholas and Murray, Briana P and Walker, Ian M and others},
  title   = {{Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia}},
  journal = {Brain sciences},
  year    = {2024},
  doi     = {10.3390/brainsci14121163},
  pmid    = {39766362},
  url     = {https://doi.org/10.3390/brainsci14121163}
}

@article{jann2000-10641971,
  author  = {Jann, M W},
  title   = {{Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease}},
  journal = {Pharmacotherapy},
  year    = {2000},
  doi     = {10.1592/phco.20.1.1.34664},
  pmid    = {10641971},
  url     = {https://doi.org/10.1592/phco.20.1.1.34664}
}

@article{mouradian1988-3281057,
  author  = {Mouradian, M M and Mohr, E and Williams, J A and Chase, T N},
  title   = {{No response to high-dose muscarinic agonist therapy in Alzheimer's disease}},
  journal = {Neurology},
  year    = {1988},
  doi     = {10.1212/wnl.38.4.606},
  pmid    = {3281057},
  url     = {https://doi.org/10.1212/wnl.38.4.606}
}

@article{koola2020-32829072,
  author  = {Koola, Maju Mathew},
  title   = {{Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond}},
  journal = {Psychiatry research},
  year    = {2020},
  doi     = {10.1016/j.psychres.2020.113409},
  pmid    = {32829072},
  url     = {https://doi.org/10.1016/j.psychres.2020.113409}
}

@article{cummings2025-39971900,
  author  = {Cummings, Jeffrey L and Zhou, Yadi and Van Stone, Alexandra and Cammann, Davis and Tonegawa-Kuji, Reina and Fonseca, Jorge and Cheng, Feixiong},
  title   = {{Drug repurposing for Alzheimer's disease and other neurodegenerative disorders}},
  journal = {Nature communications},
  year    = {2025},
  doi     = {10.1038/s41467-025-56690-4},
  pmid    = {39971900},
  url     = {https://doi.org/10.1038/s41467-025-56690-4}
}

@article{zhang2024-39174535,
  author  = {Zhang, J. and Zhang, Y. and Wang, J. and Xia, Y. and Chen, L.},
  title   = {{Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies}},
  journal = {Signal transduction and targeted therapy},
  year    = {2024},
  doi     = {10.1038/s41392-024-01911-3},
  pmid    = {39174535},
  url     = {https://doi.org/10.1038/s41392-024-01911-3}
}

@article{rhea2024-38095516,
  author  = {Rhea, E. M. and Babin, A. and Thomas, P. and Omer, M. and Weaver, R. and Hansen, K. and Banks, W. A. and Talbot, K.},
  title   = {{Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases}},
  journal = {Tissue barriers},
  year    = {2024},
  doi     = {10.1080/21688370.2023.2292461},
  pmid    = {38095516},
  url     = {https://doi.org/10.1080/21688370.2023.2292461}
}

@article{etukudo2026-c4612b37,
  author  = {Etukudo, E. M. and Usman, I. M. and Oviosun, A. and Ojiakor, V. O. and Owembabazi, E. and Aja, P. M. and Anyanwu, E.},
  title   = {{Multi-Target Neuroprotection by Syzygium aromaticum Ethyl Acetate Fraction Against Mercuric Chloride-Induced Hippocampal Toxicity: Insights from Network Pharmacology, Molecular Docking, and In Vivo Evaluation}},
  journal = {F1000Res},
  year    = {2026},
  doi     = {10.12688/f1000research.186494.1},
  url     = {https://doi.org/10.12688/f1000research.186494.1}
}

@article{athar2021-34181171,
  author  = {Athar, T. and Al Balushi, K. and Khan, S. A.},
  title   = {{Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease}},
  journal = {Molecular biology reports},
  year    = {2021},
  doi     = {10.1007/s11033-021-06512-9},
  pmid    = {34181171},
  url     = {https://doi.org/10.1007/s11033-021-06512-9}
}

@article{giacobini2022-35289363,
  author  = {Giacobini, E. and Cuello, A. C. and Fisher, A.},
  title   = {{Reimagining cholinergic therapy for Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2022},
  doi     = {10.1093/brain/awac096},
  pmid    = {35289363},
  url     = {https://doi.org/10.1093/brain/awac096}
}

@article{yu2021-34360973,
  author  = {Yu, T. W. and Lane, H. Y. and Lin, C. H.},
  title   = {{Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review}},
  journal = {International journal of molecular sciences},
  year    = {2021},
  doi     = {10.3390/ijms22158208},
  pmid    = {34360973},
  url     = {https://doi.org/10.3390/ijms22158208}
}

@article{peng2023-37600514,
  author  = {Peng, Y. and Jin, H. and Xue, Y. H. and Chen, Q. and Yao, S. Y. and Du, M. Q. and Liu, S.},
  title   = {{Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks}},
  journal = {Frontiers in aging neuroscience},
  year    = {2023},
  doi     = {10.3389/fnagi.2023.1206572},
  pmid    = {37600514},
  url     = {https://doi.org/10.3389/fnagi.2023.1206572}
}

@article{holm2022-35482908,
  author  = {Holm, A. and Hansen, S. N. and Klitgaard, H. and Kauppinen, S.},
  title   = {{Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases}},
  journal = {RNA biology},
  year    = {2022},
  doi     = {10.1080/15476286.2022.2066334},
  pmid    = {35482908},
  url     = {https://doi.org/10.1080/15476286.2022.2066334}
}

@article{greig2014-24529527,
  author  = {Greig, N. H. and Tweedie, D. and Rachmany, L. and Li, Y. and Rubovitch, V. and Schreiber, S. and Chiang, Y. H. and Hoffer, B. J. and others},
  title   = {{Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2014},
  doi     = {10.1016/j.jalz.2013.12.011},
  pmid    = {24529527},
  url     = {https://doi.org/10.1016/j.jalz.2013.12.011}
}

@article{song2018-29670280,
  author  = {Song, X. and MØ, Jensen and Jogini, V. and Stein, R. A. and Lee, C. H. and Mchaourab, H. S. and Shaw, D. E. and Gouaux, E.},
  title   = {{Mechanism of NMDA receptor channel block by MK-801 and memantine}},
  journal = {Nature},
  year    = {2018},
  doi     = {10.1038/s41586-018-0039-9},
  pmid    = {29670280},
  url     = {https://doi.org/10.1038/s41586-018-0039-9}
}

@article{lamptey2022-35163773,
  author  = {Lamptey, R. N. L. and Chaulagain, B. and Trivedi, R. and Gothwal, A. and Layek, B. and Singh, J.},
  title   = {{A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics}},
  journal = {International journal of molecular sciences},
  year    = {2022},
  doi     = {10.3390/ijms23031851},
  pmid    = {35163773},
  url     = {https://doi.org/10.3390/ijms23031851}
}

@article{xie2022-34992270,
  author  = {Xie, C. and Zhuang, X. X. and Niu, Z. and Ai, R. and Lautrup, S. and Zheng, S. and Jiang, Y. and Han, R. and others},
  title   = {{Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow}},
  journal = {Nature biomedical engineering},
  year    = {2022},
  doi     = {10.1038/s41551-021-00819-5},
  pmid    = {34992270},
  url     = {https://doi.org/10.1038/s41551-021-00819-5}
}

@article{kornhuber2011-21909365,
  author  = {Kornhuber, J. and Muehlbacher, M. and Trapp, S. and Pechmann, S. and Friedl, A. and Reichel, M. and Mühle, C. and Terfloth, L. and others},
  title   = {{Identification of novel functional inhibitors of acid sphingomyelinase}},
  journal = {PloS one},
  year    = {2011},
  doi     = {10.1371/journal.pone.0023852},
  pmid    = {21909365},
  url     = {https://doi.org/10.1371/journal.pone.0023852}
}

@article{masters2025-39668075,
  author  = {Masters, Colin L},
  title   = {{Neuropathology meets chemical and genetic pathology head-on: a personal perspective}},
  journal = {Pathology},
  year    = {2025},
  doi     = {10.1016/j.pathol.2024.11.001},
  pmid    = {39668075},
  url     = {https://doi.org/10.1016/j.pathol.2024.11.001}
}

@article{ota2025-41047647,
  author  = {Ota, Miho and Arai, Tetsuaki},
  title   = {{[Pharmacological Interventions in Dementia]}},
  journal = {No shinkei geka. Neurological surgery},
  year    = {2025},
  doi     = {10.11477/mf.030126030530050943},
  pmid    = {41047647},
  url     = {https://doi.org/10.11477/mf.030126030530050943}
}

@article{weber2024-38763001,
  author  = {Weber, Patrick and Bojarová, Pavla and Brouzdová, Jitka and Křen, Vladimír and Kulik, Natalia and Stütz, Arnold E and Thonhofer, Martin and Wrodnigg, Tanja M},
  title   = {{Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase}},
  journal = {Bioorganic chemistry},
  year    = {2024},
  doi     = {10.1016/j.bioorg.2024.107452},
  pmid    = {38763001},
  url     = {https://doi.org/10.1016/j.bioorg.2024.107452}
}

@article{zhang2024-39405916,
  author  = {Zhang, Yinbing and Tang, Cheng and He, Yao and Zhang, Yingqian and Li, Qinxi and Zhang, Ting and Zhao, Bangcheng and Tong, Aiping and others},
  title   = {{Semaglutide ameliorates Alzheimer's disease and restores oxytocin in APP/PS1 mice and human brain organoid models}},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  year    = {2024},
  doi     = {10.1016/j.biopha.2024.117540},
  pmid    = {39405916},
  url     = {https://doi.org/10.1016/j.biopha.2024.117540}
}

@article{office2025-40429612,
  author  = {Office, Internation Journal Of Molecular Sciences Editorial},
  title   = {{Expression of Concern: Paladugu et al. Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer's Disease. Int. J. Mol. Sci. 2021, 22, 860}},
  journal = {International journal of molecular sciences},
  year    = {2025},
  doi     = {10.3390/ijms26104467},
  pmid    = {40429612},
  url     = {https://doi.org/10.3390/ijms26104467}
}

@article{kumar2024-38270120,
  author  = {Kumar, Ashish and Kim, Fred and Song, Dong-Keun and Choung, Jai Jun},
  title   = {{Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders}},
  journal = {Aging and disease},
  year    = {2024},
  doi     = {10.14336/ad.2023.1129},
  pmid    = {38270120},
  url     = {https://doi.org/10.14336/ad.2023.1129}
}

@article{basso2024-37990896,
  author  = {Basso, Letícia and Fagundes, Silvia Cristina and Staudt, Tatiana and da Rosa, Karini and Langaro, Elizane and Omidian, Hamid and Bertol, Charise Dallazem},
  title   = {{Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review}},
  journal = {CNS \& neurological disorders drug targets},
  year    = {2024},
  doi     = {10.2174/0118715273275957231102044934},
  pmid    = {37990896},
  url     = {https://doi.org/10.2174/0118715273275957231102044934}
}

@article{shukla2024-38942541,
  author  = {Shukla, Halak and John, Diana and Banerjee, Shuvomoy and Tiwari, Anand Krishna},
  title   = {{Drug repurposing for neurodegenerative diseases}},
  journal = {Progress in molecular biology and translational science},
  year    = {2024},
  doi     = {10.1016/bs.pmbts.2024.03.035},
  pmid    = {38942541},
  url     = {https://doi.org/10.1016/bs.pmbts.2024.03.035}
}

@article{ramos2024-38674150,
  author  = {Ramos, Raquel and Vale, Nuno},
  title   = {{Dual Drug Repurposing: The Example of Saracatinib}},
  journal = {International journal of molecular sciences},
  year    = {2024},
  doi     = {10.3390/ijms25084565},
  pmid    = {38674150},
  url     = {https://doi.org/10.3390/ijms25084565}
}

@article{barkerhaliski2025-39784685,
  author  = {Barker-Haliski, Melissa},
  title   = {{Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877241305740},
  pmid    = {39784685},
  url     = {https://doi.org/10.1177/13872877241305740}
}

@article{conceicao2024-39525305,
  author  = {Conceição, Mariana and Di Filippo, Leonardo Delello and Duarte, Jonatas Lobato and Beserra, Fernando Pereira and Gremião, Maria Palmira Daflon and Chorilli, Marlus},
  title   = {{Repurposing doxycycline for Alzheimer's treatment: Challenges from a nano-based drug delivery perspective}},
  journal = {Brain, behavior, \& immunity - health},
  year    = {2024},
  doi     = {10.1016/j.bbih.2024.100894},
  pmid    = {39525305},
  url     = {https://doi.org/10.1016/j.bbih.2024.100894}
}

@article{rohilla2024-38629171,
  author  = {Rohilla, Ankur and Rohilla, Seema},
  title   = {{Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs}},
  journal = {Current drug discovery technologies},
  year    = {2024},
  doi     = {10.2174/0115701638253929230922115127},
  pmid    = {38629171},
  url     = {https://doi.org/10.2174/0115701638253929230922115127}
}

@article{ma2025-39714451,
  author  = {Ma, Mengmeng and Wang, Jing and Guo, Kaiming and Zhong, Wenbin and Cheng, Yu and Lin, Li and Zhao, Yanli},
  title   = {{A Self-Reinforced "Microglia Energy Modulator" for Synergistic Amyloid-β Clearance in Alzheimer's Disease Model}},
  journal = {Angewandte Chemie (International ed. in English)},
  year    = {2025},
  doi     = {10.1002/anie.202420547},
  pmid    = {39714451},
  url     = {https://doi.org/10.1002/anie.202420547}
}

@article{alhorani2024-40828109,
  author  = {Al-Horani, Rami A},
  title   = {{Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight}},
  journal = {Pharmaceutical patent analyst},
  year    = {2024},
  doi     = {10.1080/20468954.2024.2363657},
  pmid    = {40828109},
  url     = {https://doi.org/10.1080/20468954.2024.2363657}
}

@article{ivanova2025-41096712,
  author  = {Ivanova, Anna V and Kutuzova, Alexandra D and Kuzmichev, Ilia A and Abakumov, Maxim A},
  title   = {{Alzheimer's Disease: From Molecular Mechanisms to Promising Therapeutic Strategies}},
  journal = {International journal of molecular sciences},
  year    = {2025},
  doi     = {10.3390/ijms26199444},
  pmid    = {41096712},
  url     = {https://doi.org/10.3390/ijms26199444}
}

@article{conway2020-32048098,
  author  = {Conway, M. E.},
  title   = {{Alzheimer's disease: targeting the glutamatergic system}},
  journal = {Biogerontology},
  year    = {2020},
  doi     = {10.1007/s10522-020-09860-4},
  pmid    = {32048098},
  url     = {https://doi.org/10.1007/s10522-020-09860-4}
}

@article{yiannopoulou2020-32165850,
  author  = {Yiannopoulou, K. G. and Papageorgiou, S. G.},
  title   = {{Current and Future Treatments in Alzheimer Disease: An Update}},
  journal = {Journal of central nervous system disease},
  year    = {2020},
  doi     = {10.1177/1179573520907397},
  pmid    = {32165850},
  url     = {https://doi.org/10.1177/1179573520907397}
}

@article{hampel2019-30569080,
  author  = {Hampel, H. and Mesulam, M. M. and Cuello, A. C. and Khachaturian, A. S. and Vergallo, A. and Farlow, M. R. and Snyder, P. J. and Giacobini, E. and others},
  title   = {{Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2019},
  doi     = {10.14283/jpad.2018.43},
  pmid    = {30569080},
  url     = {https://doi.org/10.14283/jpad.2018.43}
}

@article{joe2019-31810978,
  author  = {Joe, E. and Ringman, J. M.},
  title   = {{Cognitive symptoms of Alzheimer's disease: clinical management and prevention}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2019},
  doi     = {10.1136/bmj.l6217},
  pmid    = {31810978},
  url     = {https://doi.org/10.1136/bmj.l6217}
}

@article{dossantos2018-30405413,
  author  = {Dos Santos, T. C. and Gomes, T. M. and Pinto, B. A. S. and Camara, A. L. and Paes, A. M. A.},
  title   = {{Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy}},
  journal = {Frontiers in pharmacology},
  year    = {2018},
  doi     = {10.3389/fphar.2018.01192},
  pmid    = {30405413},
  url     = {https://doi.org/10.3389/fphar.2018.01192}
}

@article{folch2018-29254093,
  author  = {Folch, J. and Busquets, O. and Ettcheto, M. and Sánchez-López, E. and Castro-Torres, R. D. and Verdaguer, E. and Garcia, M. L. and Olloquequi, J. and others},
  title   = {{Memantine for the Treatment of Dementia: A Review on its Current and Future Applications}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-170672},
  pmid    = {29254093},
  url     = {https://doi.org/10.3233/jad-170672}
}

@article{duraes2018-29751602,
  author  = {Durães, F. and Pinto, M. and Sousa, E.},
  title   = {{Old Drugs as New Treatments for Neurodegenerative Diseases}},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  year    = {2018},
  doi     = {10.3390/ph11020044},
  pmid    = {29751602},
  url     = {https://doi.org/10.3390/ph11020044}
}

@article{davies1980-6107862,
  author  = {Davies, P. and Katzman, R. and Terry, R. D.},
  title   = {{Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa}},
  journal = {Nature},
  year    = {1980},
  doi     = {10.1038/288279a0},
  pmid    = {6107862},
  url     = {https://doi.org/10.1038/288279a0}
}

@article{hampel2018-29850777,
  author  = {Hampel, H. and Mesulam, M. M. and Cuello, A. C. and Farlow, M. R. and Giacobini, E. and Grossberg, G. T. and Khachaturian, A. S. and Vergallo, A. and others},
  title   = {{The cholinergic system in the pathophysiology and treatment of Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2018},
  doi     = {10.1093/brain/awy132},
  pmid    = {29850777},
  url     = {https://doi.org/10.1093/brain/awy132}
}

@article{singh2024-38286338,
  author  = {Singh, B. and Day, C. M. and Abdella, S. and Garg, S.},
  title   = {{Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management}},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  year    = {2024},
  doi     = {10.1016/j.jconrel.2024.01.047},
  pmid    = {38286338},
  url     = {https://doi.org/10.1016/j.jconrel.2024.01.047}
}

@article{liu2021-33406172,
  author  = {Liu, Chang and Luo, Yuxin and Wen, Huijie and Qi, Yanxia and Shi, Guoyue and Deng, Jingjing and Zhou, Tianshu},
  title   = {{Red-to-blue paper-based colorimetric sensor integrated with smartphone for point-of-use analysis of cerebral AChE upon Cd2+ exposure}},
  journal = {Nanoscale},
  year    = {2021},
  doi     = {10.1039/d0nr07449g},
  pmid    = {33406172},
  url     = {https://doi.org/10.1039/d0nr07449g}
}

@article{weber2023-37666109,
  author  = {Weber, Patrick and Mészáros, Zuzana and Bojarová, Pavla and Ebner, Manuel and Fischer, Roland and Křen, Vladimír and Kulik, Natalia and Müller, Philipp and others},
  title   = {{Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcase}},
  journal = {Bioorganic chemistry},
  year    = {2023},
  doi     = {10.1016/j.bioorg.2023.106819},
  pmid    = {37666109},
  url     = {https://doi.org/10.1016/j.bioorg.2023.106819}
}

@article{vargassoria2021-34118986,
  author  = {Vargas-Soria, Maria and Carranza-Naval, Maria Jose and Del Marco, Angel and Garcia-Alloza, Monica},
  title   = {{Role of liraglutide in Alzheimer's disease pathology}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00853-0},
  pmid    = {34118986},
  url     = {https://doi.org/10.1186/s13195-021-00853-0}
}

@article{sivaraman2022-34602041,
  author  = {Sivaraman, Bhuvaneswari and Raji, Vijaykumar and Velmurugan, Bala Aakash and Natarajan, Ramalakshmi},
  title   = {{Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease}},
  journal = {CNS \& neurological disorders drug targets},
  year    = {2022},
  doi     = {10.2174/1871527320666210928160159},
  pmid    = {34602041},
  url     = {https://doi.org/10.2174/1871527320666210928160159}
}

@article{nunes2022-36365114,
  author  = {Nunes, Débora and Loureiro, Joana A and Pereira, Maria Carmo},
  title   = {{Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer's Drugs}},
  journal = {Pharmaceutics},
  year    = {2022},
  doi     = {10.3390/pharmaceutics14112296},
  pmid    = {36365114},
  url     = {https://doi.org/10.3390/pharmaceutics14112296}
}

@article{siddique2022-35992376,
  author  = {Siddique, Yasir Hasan and Naz, Falaq and Rahul and Varshney, Himanshi},
  title   = {{Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease}},
  journal = {Current research in pharmacology and drug discovery},
  year    = {2022},
  doi     = {10.1016/j.crphar.2022.100120},
  pmid    = {35992376},
  url     = {https://doi.org/10.1016/j.crphar.2022.100120}
}

@article{vandam2005-15654502,
  author  = {Van Dam, Debby and Abramowski, Dorothee and Staufenbiel, Matthias and De Deyn, Peter Paul},
  title   = {{Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model}},
  journal = {Psychopharmacology},
  year    = {2005},
  doi     = {10.1007/s00213-004-2132-z},
  pmid    = {15654502},
  url     = {https://doi.org/10.1007/s00213-004-2132-z}
}

@article{kassa2023-37051629,
  author  = {Kassa, Jiri and Karasova, Jana Zdarova},
  title   = {{Combination of acetylcholinesterase inhibitors and NMDA receptor antagonists increases survival rate in soman-poisoned mice}},
  journal = {Toxicology mechanisms and methods},
  year    = {2023},
  doi     = {10.1080/15376516.2023.2202730},
  pmid    = {37051629},
  url     = {https://doi.org/10.1080/15376516.2023.2202730}
}

@article{przybylowska2021-33342413,
  author  = {Przybyłowska, Maja and Dzierzbicka, Krystyna and Kowalski, Szymon and Chmielewska, Klaudia and Inkielewicz-Stepniak, Iwona},
  title   = {{Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors}},
  journal = {Current neuropharmacology},
  year    = {2021},
  doi     = {10.2174/1570159x19666201218103434},
  pmid    = {33342413},
  url     = {https://doi.org/10.2174/1570159x19666201218103434}
}

@article{ahmed2021-33915501,
  author  = {Ahmed, Sagheer and Khan, Sidrah Tariq and Zargaham, Muhammad Kazim and Khan, Arif Ullah and Khan, Saeed and Hussain, Abrar and Uddin, Jalal and Khan, Ajmal and others},
  title   = {{Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase}},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  year    = {2021},
  doi     = {10.1016/j.biopha.2021.111609},
  pmid    = {33915501},
  url     = {https://doi.org/10.1016/j.biopha.2021.111609}
}

@article{singh2023-37694498,
  author  = {Singh, Yash Pal and Kumar, Navneet and Chauhan, Brijesh Singh and Garg, Prabha},
  title   = {{Carbamate as a potential anti-Alzheimer's pharmacophore: A review}},
  journal = {Drug development research},
  year    = {2023},
  doi     = {10.1002/ddr.22113},
  pmid    = {37694498},
  url     = {https://doi.org/10.1002/ddr.22113}
}

@article{singh2023-37675624,
  author  = {Singh, Yash P and Kumar, Harish},
  title   = {{Tryptamine: A privileged scaffold for the management of Alzheimer's disease}},
  journal = {Drug development research},
  year    = {2023},
  doi     = {10.1002/ddr.22111},
  pmid    = {37675624},
  url     = {https://doi.org/10.1002/ddr.22111}
}

@article{basagni2023-37734258,
  author  = {Basagni, Filippo and Ortega, Jose A and Bertozzi, Sine M and Armirotti, Andrea and Summa, Maria and Bertorelli, Rosalia and Bartolini, Manuela and Mellor, Ian R and others},
  title   = {{Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties}},
  journal = {European journal of medicinal chemistry},
  year    = {2023},
  doi     = {10.1016/j.ejmech.2023.115803},
  pmid    = {37734258},
  url     = {https://doi.org/10.1016/j.ejmech.2023.115803}
}

@article{neha2023-36529440,
  author  = {Neha and Parvez, Suhel},
  title   = {{Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease}},
  journal = {Ageing research reviews},
  year    = {2023},
  doi     = {10.1016/j.arr.2022.101815},
  pmid    = {36529440},
  url     = {https://doi.org/10.1016/j.arr.2022.101815}
}

@article{mohle2023-37508364,
  author  = {Möhle, Luisa and Stefan, Katja and Bascuñana, Pablo and Brackhan, Mirjam and Brüning, Thomas and Eiriz, Ivan and El Menuawy, Ahmed and van Genderen, Sylvie and others},
  title   = {{ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer's Disease}},
  journal = {Biology},
  year    = {2023},
  doi     = {10.3390/biology12070932},
  pmid    = {37508364},
  url     = {https://doi.org/10.3390/biology12070932}
}

@article{jimenez2023-36677633,
  author  = {Jiménez, Elvia Mera and Żołek, Teresa and Perez, Paola Gabriela Hernández and Ruvalcaba, Rene Miranda and Nicolás-Vázquez, María Inés and Hernández-Rodríguez, Maricarmen},
  title   = {{Drug Repurposing to Inhibit Histamine N-Methyl Transferase}},
  journal = {Molecules (Basel, Switzerland)},
  year    = {2023},
  doi     = {10.3390/molecules28020576},
  pmid    = {36677633},
  url     = {https://doi.org/10.3390/molecules28020576}
}

@article{savva2022-35386099,
  author  = {Savva, Kyriaki and Zachariou, Margarita and Bourdakou, Marilena M and Dietis, Nikolas and Spyrou, George M},
  title   = {{Network-based stage-specific drug repurposing for Alzheimer's disease}},
  journal = {Computational and structural biotechnology journal},
  year    = {2022},
  doi     = {10.1016/j.csbj.2022.03.013},
  pmid    = {35386099},
  url     = {https://doi.org/10.1016/j.csbj.2022.03.013}
}

@article{nam2021-34482237,
  author  = {Nam, Geewoo and Suh, Jong-Min and Yi, Yelim and Lim, Mi Hee},
  title   = {{Drug repurposing: small molecules against Cu(II)-amyloid-β and free radicals}},
  journal = {Journal of inorganic biochemistry},
  year    = {2021},
  doi     = {10.1016/j.jinorgbio.2021.111592},
  pmid    = {34482237},
  url     = {https://doi.org/10.1016/j.jinorgbio.2021.111592}
}

@article{kakoti2022-36263141,
  author  = {Kakoti, Bibhuti Bhusan and Bezbaruah, Rajashri and Ahmed, Nasima},
  title   = {{Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues}},
  journal = {Frontiers in pharmacology},
  year    = {2022},
  doi     = {10.3389/fphar.2022.1007315},
  pmid    = {36263141},
  url     = {https://doi.org/10.3389/fphar.2022.1007315}
}

@article{bayraktar2023-37210557,
  author  = {Bayraktar, Abdulahad and Li, Xiangyu and Kim, Woonghee and Zhang, Cheng and Turkez, Hasan and Shoaie, Saeed and Mardinoglu, Adil},
  title   = {{Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients}},
  journal = {Journal of translational medicine},
  year    = {2023},
  doi     = {10.1186/s12967-023-04192-6},
  pmid    = {37210557},
  url     = {https://doi.org/10.1186/s12967-023-04192-6}
}

@article{agarwal2023-35733313,
  author  = {Agarwal, Kritie and Katare, Deepshikha Pande and Jakhmola-Mani, Ruchi},
  title   = {{Foresee Novel Targets for Alzheimer's Disease by Investigating Repurposed Drugs}},
  journal = {CNS \& neurological disorders drug targets},
  year    = {2023},
  doi     = {10.2174/1871527321666220622162622},
  pmid    = {35733313},
  url     = {https://doi.org/10.2174/1871527321666220622162622}
}

@article{sanchezlopez2018-29587747,
  author  = {Sánchez‐López, Elena and Ettcheto, Miren and Egea, María Antonia and Espina, Marta and Cano, Amanda C. and Calpena, Ana Cristina and Camins, Antoni and Carmona-Ule, Nuria and others},
  title   = {{Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization}},
  journal = {Journal of Nanobiotechnology},
  year    = {2018},
  doi     = {10.1186/s12951-018-0356-z},
  pmid    = {29587747},
  url     = {https://doi.org/10.1186/s12951-018-0356-z}
}

@article{viayna2021-33356266,
  author  = {Viayna, E. and Coquelle, N. and Cieslikiewicz-Bouet, M. and Cisternas, P. and Oliva, C. A. and Sánchez-López, E. and Ettcheto, M. and Bartolini, M. and others},
  title   = {{Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice}},
  journal = {Journal of medicinal chemistry},
  year    = {2021},
  doi     = {10.1021/acs.jmedchem.0c01775},
  pmid    = {33356266},
  url     = {https://doi.org/10.1021/acs.jmedchem.0c01775}
}

@article{gao2014-24595206,
  author  = {Gao, N. and Sun, H. and Dong, K. and Ren, J. and Duan, T. and Xu, C. and Qu, X.},
  title   = {{Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2014},
  doi     = {10.1038/ncomms4422},
  pmid    = {24595206},
  url     = {https://doi.org/10.1038/ncomms4422}
}

@article{unzeta2016-27252617,
  author  = {Unzeta, M. and Esteban, G. and Bolea, I. and Fogel, W. A. and Ramsay, R. R. and Youdim, M. B. and Tipton, K. F. and Marco-Contelles, J.},
  title   = {{Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease}},
  journal = {Frontiers in neuroscience},
  year    = {2016},
  doi     = {10.3389/fnins.2016.00205},
  pmid    = {27252617},
  url     = {https://doi.org/10.3389/fnins.2016.00205}
}

@article{pollak2005-15852394,
  author  = {Pollak, Y. and Gilboa, A. and Ben-Menachem, O. and Ben-Hur, T. and Soreq, H. and Yirmiya, R.},
  title   = {{Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production}},
  journal = {Annals of neurology},
  year    = {2005},
  doi     = {10.1002/ana.20454},
  pmid    = {15852394},
  url     = {https://doi.org/10.1002/ana.20454}
}

@article{hughes2016-27199640,
  author  = {Hughes, R. E. and Nikolic, K. and Ramsay, R. R.},
  title   = {{One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug}},
  journal = {Frontiers in neuroscience},
  year    = {2016},
  doi     = {10.3389/fnins.2016.00177},
  pmid    = {27199640},
  url     = {https://doi.org/10.3389/fnins.2016.00177}
}

@article{colovic2013-24179466,
  author  = {Colović, M. B. and Krstić, D. Z. and Lazarević-Pašti, T. D. and Bondžić, A. M. and Vasić, V. M.},
  title   = {{Acetylcholinesterase inhibitors: pharmacology and toxicology}},
  journal = {Current neuropharmacology},
  year    = {2013},
  doi     = {10.2174/1570159x11311030006},
  pmid    = {24179466},
  url     = {https://doi.org/10.2174/1570159x11311030006}
}

@article{marucci2021-33035532,
  author  = {Marucci, G. and Buccioni, M. and Ben, D. D. and Lambertucci, C. and Volpini, R. and Amenta, F.},
  title   = {{Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease}},
  journal = {Neuropharmacology},
  year    = {2021},
  doi     = {10.1016/j.neuropharm.2020.108352},
  pmid    = {33035532},
  url     = {https://doi.org/10.1016/j.neuropharm.2020.108352}
}

@article{scarpini2003-12941576,
  author  = {Scarpini, E. and Scheltens, P. and Feldman, H.},
  title   = {{Treatment of Alzheimer's disease: current status and new perspectives}},
  journal = {The Lancet. Neurology},
  year    = {2003},
  doi     = {10.1016/s1474-4422(03)00502-7},
  pmid    = {12941576},
  url     = {https://doi.org/10.1016/s1474-4422(03)00502-7}
}

@article{parsons2013-23657927,
  author  = {Parsons, C. G. and Danysz, W. and Dekundy, A. and Pulte, I.},
  title   = {{Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease}},
  journal = {Neurotoxicity research},
  year    = {2013},
  doi     = {10.1007/s12640-013-9398-z},
  pmid    = {23657927},
  url     = {https://doi.org/10.1007/s12640-013-9398-z}
}

@article{parsons1995-8570022,
  author  = {Parsons, C. G. and Quack, G. and Bresink, I. and Baran, L. and Przegalinski, E. and Kostowski, W. and Krzascik, P. and Hartmann, S. and others},
  title   = {{Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo}},
  journal = {Neuropharmacology},
  year    = {1995},
  doi     = {10.1016/0028-3908(95)00092-k},
  pmid    = {8570022},
  url     = {https://doi.org/10.1016/0028-3908(95)00092-k}
}

@article{guzior2015-25386820,
  author  = {Guzior, N. and Wieckowska, A. and Panek, D. and Malawska, B.},
  title   = {{Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease}},
  journal = {Current medicinal chemistry},
  year    = {2015},
  doi     = {10.2174/0929867321666141106122628},
  pmid    = {25386820},
  url     = {https://doi.org/10.2174/0929867321666141106122628}
}

@article{fazil2012-22561106,
  author  = {Fazil, M. and Md, S. and Haque, S. and Kumar, M. and Baboota, S. and Sahni, J. K. and Ali, J.},
  title   = {{Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting}},
  journal = {European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  year    = {2012},
  doi     = {10.1016/j.ejps.2012.04.013},
  pmid    = {22561106},
  url     = {https://doi.org/10.1016/j.ejps.2012.04.013}
}

@article{mehta2012-22216416,
  author  = {Mehta, M. and Adem, A. and Sabbagh, M.},
  title   = {{New acetylcholinesterase inhibitors for Alzheimer's disease}},
  journal = {International journal of Alzheimer's disease},
  year    = {2012},
  doi     = {10.1155/2012/728983},
  pmid    = {22216416},
  url     = {https://doi.org/10.1155/2012/728983}
}

@article{nath2000-10665489,
  author  = {Nath, A. and Haughey, N. J. and Jones, M. and Anderson, C. and Bell, J. E. and Geiger, J. D.},
  title   = {{Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine}},
  journal = {Annals of neurology},
  year    = {2000},
  doi     = {10.1002/1531-8249(200002)47:2<186::aid-ana8>3.0.co;2-3},
  pmid    = {10665489},
  url     = {https://doi.org/10.1002/1531-8249(200002)47:2<186::aid-ana8>3.0.co;2-3}
}

@article{butterfield2003-12828500,
  author  = {Butterfield, D. A. and Pocernich, C. B.},
  title   = {{The glutamatergic system and Alzheimer's disease: therapeutic implications}},
  journal = {CNS drugs},
  year    = {2003},
  doi     = {10.2165/00023210-200317090-00004},
  pmid    = {12828500},
  url     = {https://doi.org/10.2165/00023210-200317090-00004}
}

@article{javitt2004-15278097,
  author  = {Javitt, D. C.},
  title   = {{Glutamate as a therapeutic target in psychiatric disorders}},
  journal = {Molecular psychiatry},
  year    = {2004},
  doi     = {10.1038/sj.mp.4001551},
  pmid    = {15278097},
  url     = {https://doi.org/10.1038/sj.mp.4001551}
}

@article{perry1978-719462,
  author  = {Perry, E. K. and Tomlinson, B. E. and Blessed, G. and Bergmann, K. and Gibson, P. H. and Perry, R. H.},
  title   = {{Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia}},
  journal = {British medical journal},
  year    = {1978},
  doi     = {10.1136/bmj.2.6150.1457},
  pmid    = {719462},
  url     = {https://doi.org/10.1136/bmj.2.6150.1457}
}

@article{pohanka2011-21731462,
  author  = {Pohanka, M. and Hrabinova, M. and Kuca, K. and Simonato, J. P.},
  title   = {{Assessment of acetylcholinesterase activity using indoxylacetate and comparison with the standard Ellman's method}},
  journal = {International journal of molecular sciences},
  year    = {2011},
  doi     = {10.3390/ijms12042631},
  pmid    = {21731462},
  url     = {https://doi.org/10.3390/ijms12042631}
}

@article{hanson2008-19091002,
  author  = {Hanson, L. R. and Frey, W. H.},
  title   = {{Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease}},
  journal = {BMC neuroscience},
  year    = {2008},
  doi     = {10.1186/1471-2202-9-s3-s5},
  pmid    = {19091002},
  url     = {https://doi.org/10.1186/1471-2202-9-s3-s5}
}

@article{santos2016-26858637,
  author  = {Santos, Sónia Sá and Santos, Sara and Pinto, Antónia R. T. and Ramu, Vasanthakumar Ganga and Heras, Montserrat and Bardajı́, Eduard and Tavares, Isaura and Castanho, Miguel A. R. B.},
  title   = {{Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model}},
  journal = {Frontiers in Aging Neuroscience},
  year    = {2016},
  doi     = {10.3389/fnagi.2016.00001},
  pmid    = {26858637},
  url     = {https://doi.org/10.3389/fnagi.2016.00001}
}

@article{sugimoto2002-12083745,
  author  = {Sugimoto, Hachiro and Ogura, Hiroo and Arai, Yasuo and Iimura, Youichi and Yamanishi, Yoshiharu},
  title   = {{Research and Development of Donepezil Hydrochloride, a New Type of Acetylcholinesterase Inhibitor}},
  journal = {The Japanese Journal of Pharmacology},
  year    = {2002},
  doi     = {10.1254/jjp.89.7},
  pmid    = {12083745},
  url     = {https://doi.org/10.1254/jjp.89.7}
}

@article{perry1978-703927,
  author  = {Perry, Elaine King and Perry, Robert H. and Blessed, Garry and Tomlinson, B. E.},
  title   = {{CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE}},
  journal = {Neuropathology and Applied Neurobiology},
  year    = {1978},
  doi     = {10.1111/j.1365-2990.1978.tb00545.x},
  pmid    = {703927},
  url     = {https://doi.org/10.1111/j.1365-2990.1978.tb00545.x}
}

@article{zhang2021-33503372,
  author  = {Zhang, Qian Jiang and Fu, Caixia and Guo, Xinjie and Gao, Jian and Zhang, Peng and Ding, Caifeng},
  title   = {{Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection}},
  journal = {ACS Sensors},
  year    = {2021},
  doi     = {10.1021/acssensors.0c02398},
  pmid    = {33503372},
  url     = {https://doi.org/10.1021/acssensors.0c02398}
}

@article{gozes1996-8552653,
  author  = {Gozes, Illana and Bardea, Amos and Reshef, Ayelet and Zamostiano, Rachel and Zhukovsky, S and Rubinraut, Sarah and Fridkin, Mati and Brenneman, Douglas E.},
  title   = {{Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide}},
  journal = {Proceedings of the National Academy of Sciences},
  year    = {1996},
  doi     = {10.1073/pnas.93.1.427},
  pmid    = {8552653},
  url     = {https://doi.org/10.1073/pnas.93.1.427}
}

@article{kabir2019-31593530,
  author  = {Kabir, Md Tanvir and Uddin, Md Sahab and Begum, Mst Marium and Thangapandiyan, Shanmugam and Rahman, Md Sohanur and Aleya, Lotfi and Mathew, Bijo and Ahmed, Muniruddin and others},
  title   = {{Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning}},
  journal = {Current pharmaceutical design},
  year    = {2019},
  doi     = {10.2174/1381612825666191008103141},
  pmid    = {31593530},
  url     = {https://doi.org/10.2174/1381612825666191008103141}
}

@article{sharma2020-31773661,
  author  = {Sharma, Piyoosh and Tripathi, Manish Kumar and Shrivastava, Sushant Kumar},
  title   = {{Cholinesterase as a Target for Drug Development in Alzheimer's Disease}},
  journal = {Methods in molecular biology (Clifton, N.J.)},
  year    = {2020},
  doi     = {10.1007/978-1-0716-0163-1_18},
  pmid    = {31773661},
  url     = {https://doi.org/10.1007/978-1-0716-0163-1_18}
}

@article{siafaka2020-32552655,
  author  = {Siafaka, Panoraia I and Bülbül, Ece Ö and Mutlu, Gökce and Okur, Mehmet E and Karantas, Ioannis D and Okur, Neslihan Ü},
  title   = {{Transdermal Drug Delivery Systems and their Potential in Alzheimer's Disease Management}},
  journal = {CNS \& neurological disorders drug targets},
  year    = {2020},
  doi     = {10.2174/1871527319666200618150046},
  pmid    = {32552655},
  url     = {https://doi.org/10.2174/1871527319666200618150046}
}

@article{goyal2018-29742314,
  author  = {Goyal, Deepti and Kaur, Amandeep and Goyal, Bhupesh},
  title   = {{Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease}},
  journal = {ChemMedChem},
  year    = {2018},
  doi     = {10.1002/cmdc.201800156},
  pmid    = {29742314},
  url     = {https://doi.org/10.1002/cmdc.201800156}
}

@article{dembitsky2020-32037088,
  author  = {Dembitsky, Valery M and Dzhemileva, Lilya and Gloriozova, Tatyana and D'yakonov, Vladimir},
  title   = {{Natural and synthetic drugs used for the treatment of the dementia}},
  journal = {Biochemical and biophysical research communications},
  year    = {2020},
  doi     = {10.1016/j.bbrc.2020.01.123},
  pmid    = {32037088},
  url     = {https://doi.org/10.1016/j.bbrc.2020.01.123}
}

@article{ali2017-28711758,
  author  = {Ali, M Rejwan and Sadoqi, Mostafa and Møller, Simon G and Boutajangout, Allal and Mezei, Mihaly},
  title   = {{Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies}},
  journal = {Journal of molecular graphics \& modelling},
  year    = {2017},
  doi     = {10.1016/j.jmgm.2017.06.027},
  pmid    = {28711758},
  url     = {https://doi.org/10.1016/j.jmgm.2017.06.027}
}

@article{cacabelos2020-32520597,
  author  = {Cacabelos, Ramón},
  title   = {{Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease}},
  journal = {Expert opinion on drug metabolism \& toxicology},
  year    = {2020},
  doi     = {10.1080/17425255.2020.1779700},
  pmid    = {32520597},
  url     = {https://doi.org/10.1080/17425255.2020.1779700}
}

@article{agatonovickustrin2018-29990843,
  author  = {Agatonovic-Kustrin, Snezana and Kettle, Christine and Morton, David W},
  title   = {{A molecular approach in drug development for Alzheimer's disease}},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  year    = {2018},
  doi     = {10.1016/j.biopha.2018.06.147},
  pmid    = {29990843},
  url     = {https://doi.org/10.1016/j.biopha.2018.06.147}
}

@article{martins2020-32933034,
  author  = {Martins, Márcia and Silva, Renata and Pinto, Madalena M M and Sousa, Emília},
  title   = {{Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease}},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  year    = {2020},
  doi     = {10.3390/ph13090242},
  pmid    = {32933034},
  url     = {https://doi.org/10.3390/ph13090242}
}

@article{paranjpe2019-31326236,
  author  = {Paranjpe, Manish D and Taubes, Alice and Sirota, Marina},
  title   = {{Insights into Computational Drug Repurposing for Neurodegenerative Disease}},
  journal = {Trends in pharmacological sciences},
  year    = {2019},
  doi     = {10.1016/j.tips.2019.06.003},
  pmid    = {31326236},
  url     = {https://doi.org/10.1016/j.tips.2019.06.003}
}

@article{markowiczpiasecka2017-28770024,
  author  = {Markowicz-Piasecka, Magdalena and Sikora, Joanna and Mateusiak, Łukasz and Mikiciuk-Olasik, Elżbieta and Huttunen, Kristiina M},
  title   = {{Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity}},
  journal = {Oxidative medicine and cellular longevity},
  year    = {2017},
  doi     = {10.1155/2017/7303096},
  pmid    = {28770024},
  url     = {https://doi.org/10.1155/2017/7303096}
}

@article{hassan2019-30551512,
  author  = {Hassan, Mubashir and Raza, Hussain and Abbasi, Muhammad Athar and Moustafa, Ahmed A and Seo, Sung-Yum},
  title   = {{The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches}},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  year    = {2019},
  doi     = {10.1016/j.biopha.2018.11.115},
  pmid    = {30551512},
  url     = {https://doi.org/10.1016/j.biopha.2018.11.115}
}

@article{darrigo2018-31105226,
  author  = {D'Arrigo, Joseph S},
  title   = {{Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood⁻Brain Barrier}},
  journal = {Biomimetics (Basel, Switzerland)},
  year    = {2018},
  doi     = {10.3390/biomimetics3010004},
  pmid    = {31105226},
  url     = {https://doi.org/10.3390/biomimetics3010004}
}

@article{kondo2017-29166618,
  author  = {Kondo, T. and Imamura, K. and Funayama, M. and Tsukita, K. and Miyake, M. and Ohta, A. and Woltjen, K. and Nakagawa, M. and others},
  title   = {{iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease}},
  journal = {Cell reports},
  year    = {2017},
  doi     = {10.1016/j.celrep.2017.10.109},
  pmid    = {29166618},
  url     = {https://doi.org/10.1016/j.celrep.2017.10.109}
}

@article{prati2018-28749667,
  author  = {Prati, F. and Bottegoni, G. and Bolognesi, M. L. and Cavalli, A.},
  title   = {{BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease}},
  journal = {Journal of medicinal chemistry},
  year    = {2018},
  doi     = {10.1021/acs.jmedchem.7b00393},
  pmid    = {28749667},
  url     = {https://doi.org/10.1021/acs.jmedchem.7b00393}
}

@article{bennett2019-31283897,
  author  = {Bennett, C. F. and Krainer, A. R. and Cleveland, D. W.},
  title   = {{Antisense Oligonucleotide Therapies for Neurodegenerative Diseases}},
  journal = {Annual review of neuroscience},
  year    = {2019},
  doi     = {10.1146/annurev-neuro-070918-050501},
  pmid    = {31283897},
  url     = {https://doi.org/10.1146/annurev-neuro-070918-050501}
}

@article{li2018-29486118,
  author  = {Li, Y. and Ji, W. and Lu, Z. and Liu, L. and Shi, Y. and Ma, G. and Zhang, X.},
  title   = {{Positively Charged Polyprodrug Amphiphiles with Enhanced Drug Loading and Reactive Oxygen Species-Responsive Release Ability for Traceable Synergistic Therapy}},
  journal = {Journal of the American Chemical Society},
  year    = {2018},
  doi     = {10.1021/jacs.8b01641},
  pmid    = {29486118},
  url     = {https://doi.org/10.1021/jacs.8b01641}
}

@article{yulug2018-29315976,
  author  = {Yulug, B. and Hanoglu, L. and Ozansoy, M. and Isık, D. and Kilic, U. and Kilic, E. and Schabitz, W. R.},
  title   = {{Therapeutic role of rifampicin in Alzheimer's disease}},
  journal = {Psychiatry and clinical neurosciences},
  year    = {2018},
  doi     = {10.1111/pcn.12637},
  pmid    = {29315976},
  url     = {https://doi.org/10.1111/pcn.12637}
}

@article{lao2019-29732929,
  author  = {Lao, K. and Ji, N. and Zhang, X. and Qiao, W. and Tang, Z. and Gou, X.},
  title   = {{Drug development for Alzheimer's disease: review}},
  journal = {Journal of drug targeting},
  year    = {2019},
  doi     = {10.1080/1061186x.2018.1474361},
  pmid    = {29732929},
  url     = {https://doi.org/10.1080/1061186x.2018.1474361}
}

@article{agrawal2018-29772289,
  author  = {Agrawal, M. and Saraf, S. and Antimisiaris, S. G. and Chougule, M. B. and Shoyele, S. A. and Alexander, A.},
  title   = {{Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs}},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  year    = {2018},
  doi     = {10.1016/j.jconrel.2018.05.011},
  pmid    = {29772289},
  url     = {https://doi.org/10.1016/j.jconrel.2018.05.011}
}

@article{hauser2017-29075003,
  author  = {Hauser, A. S. and Attwood, M. M. and Rask-Andersen, M. and Schiöth, H. B. and Gloriam, D. E.},
  title   = {{Trends in GPCR drug discovery: new agents, targets and indications}},
  journal = {Nature reviews. Drug discovery},
  year    = {2017},
  doi     = {10.1038/nrd.2017.178},
  pmid    = {29075003},
  url     = {https://doi.org/10.1038/nrd.2017.178}
}

@article{liu2014-24680748,
  author  = {Liu, Junjun and Liu, Shuyu and Tanabe, Chiaki and Maeda, Tomoji and Zou, Kun and Komano, Hiroto},
  title   = {{Differential effects of angiotensin II receptor blockers on Aβ generation}},
  journal = {Neuroscience letters},
  year    = {2014},
  doi     = {10.1016/j.neulet.2014.03.030},
  pmid    = {24680748},
  url     = {https://doi.org/10.1016/j.neulet.2014.03.030}
}

@article{pepeu2009-19355843,
  author  = {Pepeu, Giancarlo and Giovannini, Maria Grazia},
  title   = {{Cholinesterase inhibitors and beyond}},
  journal = {Current Alzheimer research},
  year    = {2009},
  doi     = {10.2174/156720509787602861},
  pmid    = {19355843},
  url     = {https://doi.org/10.2174/156720509787602861}
}

@article{dasilva2016-26760993,
  author  = {da Silva, Cristiane Bezerra and Pott, Arnildo and Elifio-Esposito, Selene and Dalarmi, Luciane and Nascimento, Kátia Fialho do and Burci, Ligia Moura and de Oliveira, Maislian and Dias, Josiane de Fátima Gaspari and others},
  title   = {{Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina}},
  journal = {Molecules (Basel, Switzerland)},
  year    = {2016},
  doi     = {10.3390/molecules21010053},
  pmid    = {26760993},
  url     = {https://doi.org/10.3390/molecules21010053}
}

@article{creeley2008-17112636,
  author  = {Creeley, Catherine E and Wozniak, David F and Nardi, Anthony and Farber, Nuri B and Olney, John W},
  title   = {{Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain}},
  journal = {Neurobiology of aging},
  year    = {2008},
  doi     = {10.1016/j.neurobiolaging.2006.10.020},
  pmid    = {17112636},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2006.10.020}
}

@article{gottwald1999-11139819,
  author  = {Gottwald, MD and Rozanski, RI},
  title   = {{Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status}},
  journal = {Expert opinion on investigational drugs},
  year    = {1999},
  doi     = {10.1517/13543784.8.10.1673},
  pmid    = {11139819},
  url     = {https://doi.org/10.1517/13543784.8.10.1673}
}

@article{lopes2013-23532860,
  author  = {Lopes, João P and Tarozzo, Glauco and Reggiani, Angelo and Piomelli, Daniele and Cavalli, Andrea},
  title   = {{Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity}},
  journal = {Brain and behavior},
  year    = {2013},
  doi     = {10.1002/brb3.118},
  pmid    = {23532860},
  url     = {https://doi.org/10.1002/brb3.118}
}

@article{zhang2015-25446738,
  author  = {Zhang, Xiu-Zhen and Quan, Yuan and Tang, Guang-Yan},
  title   = {{Medical genetics-based drug repurposing for Alzheimer's disease}},
  journal = {Brain research bulletin},
  year    = {2015},
  doi     = {10.1016/j.brainresbull.2014.11.003},
  pmid    = {25446738},
  url     = {https://doi.org/10.1016/j.brainresbull.2014.11.003}
}

@article{zhang2016-28005991,
  author  = {Zhang, Ming and Schmitt-Ulms, Gerold and Sato, Christine and Xi, Zhengrui and Zhang, Yalun and Zhou, Ye and George-Hyslop, Peter St and Rogaeva, Ekaterina},
  title   = {{Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining}},
  journal = {PloS one},
  year    = {2016},
  doi     = {10.1371/journal.pone.0168812},
  pmid    = {28005991},
  url     = {https://doi.org/10.1371/journal.pone.0168812}
}

@article{davies1979-37989,
  author  = {Davies, P.},
  title   = {{Neurotransmitter-related enzymes in senile dementia of the Alzheimer type}},
  journal = {Brain research},
  year    = {1979},
  doi     = {10.1016/0006-8993(79)90336-6},
  pmid    = {37989},
  url     = {https://doi.org/10.1016/0006-8993(79)90336-6}
}

@article{lawrence1995-8534423,
  author  = {Lawrence, A. D. and Sahakian, B. J.},
  title   = {{Alzheimer disease, attention, and the cholinergic system}},
  journal = {Alzheimer disease and associated disorders},
  year    = {1995},
  doi     = {10.1097/00002093-199501002-00008},
  pmid    = {8534423},
  url     = {https://doi.org/10.1097/00002093-199501002-00008}
}

@article{sinkus2015-25701707,
  author  = {Sinkus, M. L. and Graw, S. and Freedman, R. and Ross, R. G. and Lester, H. A. and Leonard, S.},
  title   = {{The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function}},
  journal = {Neuropharmacology},
  year    = {2015},
  doi     = {10.1016/j.neuropharm.2015.02.006},
  pmid    = {25701707},
  url     = {https://doi.org/10.1016/j.neuropharm.2015.02.006}
}

@article{wang2000-10681545,
  author  = {Wang, H. Y. and Lee, D. H. and D'Andrea, M. R. and Peterson, P. A. and Shank, R. P. and Reitz, A. B.},
  title   = {{beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology}},
  journal = {The Journal of biological chemistry},
  year    = {2000},
  doi     = {10.1074/jbc.275.8.5626},
  pmid    = {10681545},
  url     = {https://doi.org/10.1074/jbc.275.8.5626}
}

@article{maurice2009-19619582,
  author  = {Maurice, T. and Su, T. P.},
  title   = {{The pharmacology of sigma-1 receptors}},
  journal = {Pharmacology \& therapeutics},
  year    = {2009},
  doi     = {10.1016/j.pharmthera.2009.07.001},
  pmid    = {19619582},
  url     = {https://doi.org/10.1016/j.pharmthera.2009.07.001}
}

@article{sebastiao1996-8735876,
  author  = {Sebastião, A. M. and Ribeiro, J. A.},
  title   = {{Adenosine A2 receptor-mediated excitatory actions on the nervous system}},
  journal = {Progress in neurobiology},
  year    = {1996},
  doi     = {10.1016/0301-0082(95)00035-6},
  pmid    = {8735876},
  url     = {https://doi.org/10.1016/0301-0082(95)00035-6}
}

@article{godyn2016-26721364,
  author  = {Godyń, J. and Jończyk, J. and Panek, D. and Malawska, B.},
  title   = {{Therapeutic strategies for Alzheimer's disease in clinical trials}},
  journal = {Pharmacological reports : PR},
  year    = {2016},
  doi     = {10.1016/j.pharep.2015.07.006},
  pmid    = {26721364},
  url     = {https://doi.org/10.1016/j.pharep.2015.07.006}
}

@article{greig2004-15681814,
  author  = {Greig, N. H. and Mattson, M. P. and Perry, T. and Chan, S. L. and Giordano, T. and Sambamurti, K. and Rogers, J. T. and Ovadia, H. and others},
  title   = {{New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists}},
  journal = {Annals of the New York Academy of Sciences},
  year    = {2004},
  doi     = {10.1196/annals.1332.018},
  pmid    = {15681814},
  url     = {https://doi.org/10.1196/annals.1332.018}
}

@article{appleby2013-24059463,
  author  = {Appleby, B. S. and Cummings, J. L.},
  title   = {{Discovering new treatments for Alzheimer's disease by repurposing approved medications}},
  journal = {Current topics in medicinal chemistry},
  year    = {2013},
  doi     = {10.2174/15680266113136660162},
  pmid    = {24059463},
  url     = {https://doi.org/10.2174/15680266113136660162}
}

@article{francis1999-10071091,
  author  = {Francis, P. T. and Palmer, A. M. and Snape, M. and Wilcock, G. K.},
  title   = {{The cholinergic hypothesis of Alzheimer's disease: a review of progress}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {1999},
  doi     = {10.1136/jnnp.66.2.137},
  pmid    = {10071091},
  url     = {https://doi.org/10.1136/jnnp.66.2.137}
}

@article{cheung2012-23035744,
  author  = {Cheung, J. and Rudolph, M. J. and Burshteyn, F. and Cassidy, M. S. and Gary, E. N. and Love, J. and Franklin, M. C. and Height, J. J.},
  title   = {{Structures of human acetylcholinesterase in complex with pharmacologically important ligands}},
  journal = {Journal of medicinal chemistry},
  year    = {2012},
  doi     = {10.1021/jm300871x},
  pmid    = {23035744},
  url     = {https://doi.org/10.1021/jm300871x}
}

@article{lipton2006-16424917,
  author  = {Lipton, S. A.},
  title   = {{Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond}},
  journal = {Nature reviews. Drug discovery},
  year    = {2006},
  doi     = {10.1038/nrd1958},
  pmid    = {16424917},
  url     = {https://doi.org/10.1038/nrd1958}
}

@article{parsons2007-17904591,
  author  = {Parsons, C. G. and Stöffler, A. and Danysz, W.},
  title   = {{Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse}},
  journal = {Neuropharmacology},
  year    = {2007},
  doi     = {10.1016/j.neuropharm.2007.07.013},
  pmid    = {17904591},
  url     = {https://doi.org/10.1016/j.neuropharm.2007.07.013}
}

@article{anand2013-23435942,
  author  = {Anand, P. and Singh, B.},
  title   = {{A review on cholinesterase inhibitors for Alzheimer's disease}},
  journal = {Archives of pharmacal research},
  year    = {2013},
  doi     = {10.1007/s12272-013-0036-3},
  pmid    = {23435942},
  url     = {https://doi.org/10.1007/s12272-013-0036-3}
}

@article{maurice1996-8822355,
  author  = {Maurice, T. and Lockhart, B. P. and Privat, A.},
  title   = {{Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction}},
  journal = {Brain research},
  year    = {1996},
  doi     = {10.1016/0006-8993(95)01032-7},
  pmid    = {8822355},
  url     = {https://doi.org/10.1016/0006-8993(95)01032-7}
}

@article{yiannopoulou2013-23277790,
  author  = {Yiannopoulou, K. G. and Papageorgiou, S. G.},
  title   = {{Current and future treatments for Alzheimer's disease}},
  journal = {Therapeutic advances in neurological disorders},
  year    = {2013},
  doi     = {10.1177/1756285612461679},
  pmid    = {23277790},
  url     = {https://doi.org/10.1177/1756285612461679}
}

@article{johnson2006-16368266,
  author  = {Johnson, J. W. and Kotermanski, S. E.},
  title   = {{Mechanism of action of memantine}},
  journal = {Current opinion in pharmacology},
  year    = {2006},
  doi     = {10.1016/j.coph.2005.09.007},
  pmid    = {16368266},
  url     = {https://doi.org/10.1016/j.coph.2005.09.007}
}

@article{xia2010-20720132,
  author  = {Xia, P. and Chen, H. S. and Zhang, D. and Lipton, S. A.},
  title   = {{Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2010},
  doi     = {10.1523/jneurosci.2488-10.2010},
  pmid    = {20720132},
  url     = {https://doi.org/10.1523/jneurosci.2488-10.2010}
}

@article{greig2001-11900310,
  author  = {Greig, N. H. and Utsuki, T. and Yu, Q. and Zhu, X. and Holloway, H. W. and Perry, T. and Lee, B. and Ingram, D. K. and others},
  title   = {{A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase}},
  journal = {Current medical research and opinion},
  year    = {2001},
  doi     = {10.1185/0300799039117057},
  pmid    = {11900310},
  url     = {https://doi.org/10.1185/0300799039117057}
}

@article{chen2006-16805772,
  author  = {Chen, H. S. and Lipton, S. A.},
  title   = {{The chemical biology of clinically tolerated NMDA receptor antagonists}},
  journal = {Journal of neurochemistry},
  year    = {2006},
  doi     = {10.1111/j.1471-4159.2006.03991.x},
  pmid    = {16805772},
  url     = {https://doi.org/10.1111/j.1471-4159.2006.03991.x}
}

@article{greig2002-12636181,
  author  = {Greig, N. H. and Lahiri, D. K. and Sambamurti, K.},
  title   = {{Butyrylcholinesterase: an important new target in Alzheimer's disease therapy}},
  journal = {International psychogeriatrics},
  year    = {2002},
  doi     = {10.1017/s1041610203008676},
  pmid    = {12636181},
  url     = {https://doi.org/10.1017/s1041610203008676}
}

@article{rogawski2003-14530799,
  author  = {Rogawski, M. A. and Wenk, G. L.},
  title   = {{The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease}},
  journal = {CNS drug reviews},
  year    = {2003},
  doi     = {10.1111/j.1527-3458.2003.tb00254.x},
  pmid    = {14530799},
  url     = {https://doi.org/10.1111/j.1527-3458.2003.tb00254.x}
}

@article{olivares2012-21875407,
  author  = {Olivares, D. and Deshpande, V. K. and Shi, Y. and Lahiri, D. K. and Greig, N. H. and Rogers, J. T. and Huang, X.},
  title   = {{N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease}},
  journal = {Current Alzheimer research},
  year    = {2012},
  doi     = {10.2174/156720512801322564},
  pmid    = {21875407},
  url     = {https://doi.org/10.2174/156720512801322564}
}

@article{samochocki2003-12649296,
  author  = {Samochocki, M. and Höffle, A. and Fehrenbacher, A. and Jostock, R. and Ludwig, J. and Christner, C. and Radina, M. and Zerlin, M. and others},
  title   = {{Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors}},
  journal = {The Journal of pharmacology and experimental therapeutics},
  year    = {2003},
  doi     = {10.1124/jpet.102.045773},
  pmid    = {12649296},
  url     = {https://doi.org/10.1124/jpet.102.045773}
}

@article{danysz2003-12973747,
  author  = {Danysz, W. and Parsons, C. G.},
  title   = {{The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence}},
  journal = {International journal of geriatric psychiatry},
  year    = {2003},
  doi     = {10.1002/gps.938},
  pmid    = {12973747},
  url     = {https://doi.org/10.1002/gps.938}
}

@article{wilkinson2004-15132713,
  author  = {Wilkinson, D. G. and Francis, P. T. and Schwam, E. and Payne-Parrish, J.},
  title   = {{Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy}},
  journal = {Drugs \& aging},
  year    = {2004},
  doi     = {10.2165/00002512-200421070-00004},
  pmid    = {15132713},
  url     = {https://doi.org/10.2165/00002512-200421070-00004}
}

@article{jann2002-12162759,
  author  = {Jann, M. W. and Shirley, K. L. and Small, G. W.},
  title   = {{Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors}},
  journal = {Clinical pharmacokinetics},
  year    = {2002},
  doi     = {10.2165/00003088-200241100-00003},
  pmid    = {12162759},
  url     = {https://doi.org/10.2165/00003088-200241100-00003}
}

@article{baron2002-11888271,
  author  = {Bar-On, P. and Millard, C. B. and Harel, M. and Dvir, H. and Enz, A. and Sussman, J. L. and Silman, I.},
  title   = {{Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine}},
  journal = {Biochemistry},
  year    = {2002},
  doi     = {10.1021/bi020016x},
  pmid    = {11888271},
  url     = {https://doi.org/10.1021/bi020016x}
}

@article{nordberg1998-9880090,
  author  = {Nordberg, A. and Svensson, A. L.},
  title   = {{Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology}},
  journal = {Drug safety},
  year    = {1998},
  doi     = {10.2165/00002018-199819060-00004},
  pmid    = {9880090},
  url     = {https://doi.org/10.2165/00002018-199819060-00004}
}

@article{kotermanski2009-19261873,
  author  = {Kotermanski, S. E. and Johnson, J. W.},
  title   = {{Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2009},
  doi     = {10.1523/jneurosci.3703-08.2009},
  pmid    = {19261873},
  url     = {https://doi.org/10.1523/jneurosci.3703-08.2009}
}

@article{zemek2014-24845946,
  author  = {Zemek, F. and Drtinova, L. and Nepovimova, E. and Sepsova, V. and Korabecny, J. and Klimes, J. and Kuca, K.},
  title   = {{Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine}},
  journal = {Expert opinion on drug safety},
  year    = {2014},
  doi     = {10.1517/14740338.2014.914168},
  pmid    = {24845946},
  url     = {https://doi.org/10.1517/14740338.2014.914168}
}

@article{revett2013-22894822,
  author  = {Revett, T. J. and Baker, G. B. and Jhamandas, J. and Kar, S.},
  title   = {{Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology}},
  journal = {Journal of psychiatry \& neuroscience : JPN},
  year    = {2013},
  doi     = {10.1503/jpn.110190},
  pmid    = {22894822},
  url     = {https://doi.org/10.1503/jpn.110190}
}

@article{sugimoto2000-10637367,
  author  = {Sugimoto, H. and Yamanishi, Y. and Iimura, Y. and Kawakami, Y.},
  title   = {{Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors}},
  journal = {Current medicinal chemistry},
  year    = {2000},
  doi     = {10.2174/0929867003375191},
  pmid    = {10637367},
  url     = {https://doi.org/10.2174/0929867003375191}
}

@article{maelicke2001-11230879,
  author  = {Maelicke, A. and Samochocki, M. and Jostock, R. and Fehrenbacher, A. and Ludwig, J. and Albuquerque, E. X. and Zerlin, M.},
  title   = {{Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease}},
  journal = {Biological psychiatry},
  year    = {2001},
  doi     = {10.1016/s0006-3223(00)01109-4},
  pmid    = {11230879},
  url     = {https://doi.org/10.1016/s0006-3223(00)01109-4}
}

@article{polinsky1998-9737824,
  author  = {Polinsky, R. J.},
  title   = {{Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease}},
  journal = {Clinical therapeutics},
  year    = {1998},
  doi     = {10.1016/s0149-2918(98)80127-6},
  pmid    = {9737824},
  url     = {https://doi.org/10.1016/s0149-2918(98)80127-6}
}

@article{wilson2008-18291351,
  author  = {Wilson, B. and Samanta, M. K. and Santhi, K. and Kumar, K. P. and Paramakrishnan, N. and Suresh, B.},
  title   = {{Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease}},
  journal = {Brain research},
  year    = {2008},
  doi     = {10.1016/j.brainres.2008.01.039},
  pmid    = {18291351},
  url     = {https://doi.org/10.1016/j.brainres.2008.01.039}
}

@article{salomone2012-22035455,
  author  = {Salomone, S. and Caraci, F. and Leggio, G. M. and Fedotova, J. and Drago, F.},
  title   = {{New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs}},
  journal = {British journal of clinical pharmacology},
  year    = {2012},
  doi     = {10.1111/j.1365-2125.2011.04134.x},
  pmid    = {22035455},
  url     = {https://doi.org/10.1111/j.1365-2125.2011.04134.x}
}

@article{lopez2002-12270757,
  author  = {López, S. and Bastida, J. and Viladomat, F. and Codina, C.},
  title   = {{Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts}},
  journal = {Life sciences},
  year    = {2002},
  doi     = {10.1016/s0024-3205(02)02034-9},
  pmid    = {12270757},
  url     = {https://doi.org/10.1016/s0024-3205(02)02034-9}
}

@article{pohanka2011-22286807,
  author  = {Pohanka, M.},
  title   = {{Cholinesterases, a target of pharmacology and toxicology}},
  journal = {Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia},
  year    = {2011},
  doi     = {10.5507/bp.2011.036},
  pmid    = {22286807},
  url     = {https://doi.org/10.5507/bp.2011.036}
}

@article{francis2005-16273023,
  author  = {Francis, P. T.},
  title   = {{The interplay of neurotransmitters in Alzheimer's disease}},
  journal = {CNS spectrums},
  year    = {2005},
  doi     = {10.1017/s1092852900014164},
  pmid    = {16273023},
  url     = {https://doi.org/10.1017/s1092852900014164}
}

@article{nordberg2013-23930233,
  author  = {Nordberg, A. and Ballard, C. and Bullock, R. and Darreh-Shori, T. and Somogyi, M.},
  title   = {{A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease}},
  journal = {The primary care companion for CNS disorders},
  year    = {2013},
  doi     = {10.4088/pcc.12r01412},
  pmid    = {23930233},
  url     = {https://doi.org/10.4088/pcc.12r01412}
}

@article{bolognesi2007-18047264,
  author  = {Bolognesi, M. L. and Cavalli, A. and Valgimigli, L. and Bartolini, M. and Rosini, M. and Andrisano, V. and Recanatini, M. and Melchiorre, C.},
  title   = {{Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease}},
  journal = {Journal of medicinal chemistry},
  year    = {2007},
  doi     = {10.1021/jm701225u},
  pmid    = {18047264},
  url     = {https://doi.org/10.1021/jm701225u}
}

@article{munoztorrero2008-18855672,
  author  = {Muñoz-Torrero, D.},
  title   = {{Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease}},
  journal = {Current medicinal chemistry},
  year    = {2008},
  doi     = {10.2174/092986708785909067},
  pmid    = {18855672},
  url     = {https://doi.org/10.2174/092986708785909067}
}

@article{lipton2005-15974913,
  author  = {Lipton, S. A.},
  title   = {{The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism}},
  journal = {Current Alzheimer research},
  year    = {2005},
  doi     = {10.2174/1567205053585846},
  pmid    = {15974913},
  url     = {https://doi.org/10.2174/1567205053585846}
}

@article{ballard2002-11803198,
  author  = {Ballard, C. G.},
  title   = {{Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition}},
  journal = {European neurology},
  year    = {2002},
  doi     = {10.1159/000047952},
  pmid    = {11803198},
  url     = {https://doi.org/10.1159/000047952}
}

@article{bolea2011-22023459,
  author  = {Bolea, I. and Juárez-Jiménez, J. and de Los Ríos, C. and Chioua, M. and Pouplana, R. and Luque, F. J. and Unzeta, M. and Marco-Contelles, J. and others},
  title   = {{Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease}},
  journal = {Journal of medicinal chemistry},
  year    = {2011},
  doi     = {10.1021/jm200853t},
  pmid    = {22023459},
  url     = {https://doi.org/10.1021/jm200853t}
}

@article{racchi2004-15304241,
  author  = {Racchi, M. and Mazzucchelli, M. and Porrello, E. and Lanni, C. and Govoni, S.},
  title   = {{Acetylcholinesterase inhibitors: novel activities of old molecules}},
  journal = {Pharmacological research},
  year    = {2004},
  doi     = {10.1016/j.phrs.2003.12.027},
  pmid    = {15304241},
  url     = {https://doi.org/10.1016/j.phrs.2003.12.027}
}

@article{beaulieu2009-18928402,
  author  = {Beaulieu, J. M. and Gainetdinov, R. R. and Caron, M. G.},
  title   = {{Akt/GSK3 signaling in the action of psychotropic drugs}},
  journal = {Annual review of pharmacology and toxicology},
  year    = {2009},
  doi     = {10.1146/annurev.pharmtox.011008.145634},
  pmid    = {18928402},
  url     = {https://doi.org/10.1146/annurev.pharmtox.011008.145634}
}

@article{wang2007-17965777,
  author  = {Wang, J. and Ho, L. and Chen, L. and Zhao, Z. and Zhao, W. and Qian, X. and Humala, N. and Seror, I. and others},
  title   = {{Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease}},
  journal = {The Journal of clinical investigation},
  year    = {2007},
  doi     = {10.1172/jci31547},
  pmid    = {17965777},
  url     = {https://doi.org/10.1172/jci31547}
}

@article{sierra2011-21098985,
  author  = {Sierra, S. and Ramos, M. C. and Molina, P. and Esteo, C. and Vázquez, J. A. and Burgos, J. S.},
  title   = {{Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2011},
  doi     = {10.3233/jad-2010-101179},
  pmid    = {21098985},
  url     = {https://doi.org/10.3233/jad-2010-101179}
}

@article{roy2015-26118928,
  author  = {Roy, A. and Jana, M. and Kundu, M. and Corbett, G. T. and Rangaswamy, S. B. and Mishra, R. K. and Luan, C. H. and Gonzalez, F. J. and others},
  title   = {{HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice}},
  journal = {Cell metabolism},
  year    = {2015},
  doi     = {10.1016/j.cmet.2015.05.022},
  pmid    = {26118928},
  url     = {https://doi.org/10.1016/j.cmet.2015.05.022}
}

@article{everitt1997-9046571,
  author  = {Everitt, B. J. and Robbins, T. W.},
  title   = {{Central cholinergic systems and cognition}},
  journal = {Annual review of psychology},
  year    = {1997},
  doi     = {10.1146/annurev.psych.48.1.649},
  pmid    = {9046571},
  url     = {https://doi.org/10.1146/annurev.psych.48.1.649}
}

@article{schliebs2006-17039298,
  author  = {Schliebs, R. and Arendt, T.},
  title   = {{The significance of the cholinergic system in the brain during aging and in Alzheimer's disease}},
  journal = {Journal of neural transmission (Vienna, Austria : 1996)},
  year    = {2006},
  doi     = {10.1007/s00702-006-0579-2},
  pmid    = {17039298},
  url     = {https://doi.org/10.1007/s00702-006-0579-2}
}

@article{ribeiro2002-12576292,
  author  = {Ribeiro, J. A. and Sebastião, A. M. and de Mendonça, A.},
  title   = {{Adenosine receptors in the nervous system: pathophysiological implications}},
  journal = {Progress in neurobiology},
  year    = {2002},
  doi     = {10.1016/s0301-0082(02)00155-7},
  pmid    = {12576292},
  url     = {https://doi.org/10.1016/s0301-0082(02)00155-7}
}

@article{benowitz1996-8725403,
  author  = {Benowitz, N. L.},
  title   = {{Pharmacology of nicotine: addiction and therapeutics}},
  journal = {Annual review of pharmacology and toxicology},
  year    = {1996},
  doi     = {10.1146/annurev.pa.36.040196.003121},
  pmid    = {8725403},
  url     = {https://doi.org/10.1146/annurev.pa.36.040196.003121}
}

@article{ribeiro2010-20164566,
  author  = {Ribeiro, J. A. and Sebastião, A. M.},
  title   = {{Caffeine and adenosine}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2010},
  doi     = {10.3233/jad-2010-1379},
  pmid    = {20164566},
  url     = {https://doi.org/10.3233/jad-2010-1379}
}

@article{oda1999-10594838,
  author  = {Oda, Y.},
  title   = {{Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system}},
  journal = {Pathology international},
  year    = {1999},
  doi     = {10.1046/j.1440-1827.1999.00977.x},
  pmid    = {10594838},
  url     = {https://doi.org/10.1046/j.1440-1827.1999.00977.x}
}

@article{parsons1998-15616669,
  author  = {Parsons, C. G. and Danysz, W. and Quack, G.},
  title   = {{Glutamate in CNS disorders as a target for drug development: an update}},
  journal = {Drug news \& perspectives},
  year    = {1998},
  doi     = {10.1358/dnp.1998.11.9.863689},
  pmid    = {15616669},
  url     = {https://doi.org/10.1358/dnp.1998.11.9.863689}
}

@article{supuran2008-18167490,
  author  = {Supuran, C. T.},
  title   = {{Carbonic anhydrases: novel therapeutic applications for inhibitors and activators}},
  journal = {Nature reviews. Drug discovery},
  year    = {2008},
  doi     = {10.1038/nrd2467},
  pmid    = {18167490},
  url     = {https://doi.org/10.1038/nrd2467}
}

@article{gotti2006-16876883,
  author  = {Gotti, C. and Zoli, M. and Clementi, F.},
  title   = {{Brain nicotinic acetylcholine receptors: native subtypes and their relevance}},
  journal = {Trends in pharmacological sciences},
  year    = {2006},
  doi     = {10.1016/j.tips.2006.07.004},
  pmid    = {16876883},
  url     = {https://doi.org/10.1016/j.tips.2006.07.004}
}

@article{taly2009-19721446,
  author  = {Taly, A. and Corringer, P. J. and Guedin, D. and Lestage, P. and Changeux, J. P.},
  title   = {{Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system}},
  journal = {Nature reviews. Drug discovery},
  year    = {2009},
  doi     = {10.1038/nrd2927},
  pmid    = {19721446},
  url     = {https://doi.org/10.1038/nrd2927}
}

@article{perry1977-144789,
  author  = {Perry, E. K. and Gibson, P. H. and Blessed, G. and Perry, R. H. and Tomlinson, B. E.},
  title   = {{Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue}},
  journal = {Journal of the neurological sciences},
  year    = {1977},
  doi     = {10.1016/0022-510x(77)90073-9},
  pmid    = {144789},
  url     = {https://doi.org/10.1016/0022-510x(77)90073-9}
}

@article{casida2013-23317040,
  author  = {Casida, J. E. and Durkin, K. A.},
  title   = {{Neuroactive insecticides: targets, selectivity, resistance, and secondary effects}},
  journal = {Annual review of entomology},
  year    = {2013},
  doi     = {10.1146/annurev-ento-120811-153645},
  pmid    = {23317040},
  url     = {https://doi.org/10.1146/annurev-ento-120811-153645}
}

@article{terry2012-22465060,
  author  = {Terry, A. V.},
  title   = {{Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms}},
  journal = {Pharmacology \& therapeutics},
  year    = {2012},
  doi     = {10.1016/j.pharmthera.2012.03.001},
  pmid    = {22465060},
  url     = {https://doi.org/10.1016/j.pharmthera.2012.03.001}
}

@article{casida2005-16243304,
  author  = {Casida, J. E. and Quistad, G. B.},
  title   = {{Serine hydrolase targets of organophosphorus toxicants}},
  journal = {Chemico-biological interactions},
  year    = {2005},
  doi     = {10.1016/j.cbi.2005.10.036},
  pmid    = {16243304},
  url     = {https://doi.org/10.1016/j.cbi.2005.10.036}
}

@article{soreq2015-26100140,
  author  = {Soreq, H.},
  title   = {{Checks and balances on cholinergic signaling in brain and body function}},
  journal = {Trends in neurosciences},
  year    = {2015},
  doi     = {10.1016/j.tins.2015.05.007},
  pmid    = {26100140},
  url     = {https://doi.org/10.1016/j.tins.2015.05.007}
}

@article{millard1995-7722478,
  author  = {Millard, C. B. and Broomfield, C. A.},
  title   = {{Anticholinesterases: medical applications of neurochemical principles}},
  journal = {Journal of neurochemistry},
  year    = {1995},
  doi     = {10.1046/j.1471-4159.1995.64051909.x},
  pmid    = {7722478},
  url     = {https://doi.org/10.1046/j.1471-4159.1995.64051909.x}
}

@article{kim2011-21792905,
  author  = {Kim, K. and Lee, S. G. and Kegelman, T. P. and Su, Z. Z. and Das, S. K. and Dash, R. and Dasgupta, S. and Barral, P. M. and others},
  title   = {{Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics}},
  journal = {Journal of cellular physiology},
  year    = {2011},
  doi     = {10.1002/jcp.22609},
  pmid    = {21792905},
  url     = {https://doi.org/10.1002/jcp.22609}
}

@article{berk2013-23369637,
  author  = {Berk, M. and Malhi, G. S. and Gray, L. J. and Dean, O. M.},
  title   = {{The promise of N-acetylcysteine in neuropsychiatry}},
  journal = {Trends in pharmacological sciences},
  year    = {2013},
  doi     = {10.1016/j.tips.2013.01.001},
  pmid    = {23369637},
  url     = {https://doi.org/10.1016/j.tips.2013.01.001}
}

@article{ferrier1983-6199464,
  author  = {Ferrier, I. N. and Cross, A. J. and Johnson, J. A. and Roberts, G. W. and Crow, T. J. and Corsellis, J. A. and Lee, Y. C. and O'Shaughnessy, D. and others},
  title   = {{Neuropeptides in Alzheimer type dementia}},
  journal = {Journal of the neurological sciences},
  year    = {1983},
  doi     = {10.1016/0022-510x(83)90196-x},
  pmid    = {6199464},
  url     = {https://doi.org/10.1016/0022-510x(83)90196-x}
}

@article{albuquerque2009-19126755,
  author  = {Albuquerque, E. X. and Pereira, E. F. and Alkondon, M. and Rogers, S. W.},
  title   = {{Mammalian nicotinic acetylcholine receptors: from structure to function}},
  journal = {Physiological reviews},
  year    = {2009},
  doi     = {10.1152/physrev.00015.2008},
  pmid    = {19126755},
  url     = {https://doi.org/10.1152/physrev.00015.2008}
}

@article{hynd2004-15234100,
  author  = {Hynd, M. R. and Scott, H. L. and Dodd, P. R.},
  title   = {{Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease}},
  journal = {Neurochemistry international},
  year    = {2004},
  doi     = {10.1016/j.neuint.2004.03.007},
  pmid    = {15234100},
  url     = {https://doi.org/10.1016/j.neuint.2004.03.007}
}

@article{dvir2010-20138030,
  author  = {Dvir, H. and Silman, I. and Harel, M. and Rosenberry, T. L. and Sussman, J. L.},
  title   = {{Acetylcholinesterase: from 3D structure to function}},
  journal = {Chemico-biological interactions},
  year    = {2010},
  doi     = {10.1016/j.cbi.2010.01.042},
  pmid    = {20138030},
  url     = {https://doi.org/10.1016/j.cbi.2010.01.042}
}

@article{bartus2000-10833325,
  author  = {Bartus, R. T.},
  title   = {{On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis}},
  journal = {Experimental neurology},
  year    = {2000},
  doi     = {10.1006/exnr.2000.7397},
  pmid    = {10833325},
  url     = {https://doi.org/10.1006/exnr.2000.7397}
}

@article{houghton2005-15956811,
  author  = {Houghton, P. J. and Howes, M. J.},
  title   = {{Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease}},
  journal = {Neuro-Signals},
  year    = {2005},
  doi     = {10.1159/000085382},
  pmid    = {15956811},
  url     = {https://doi.org/10.1159/000085382}
}

@article{hutson2011-21619887,
  author  = {Hutson, P. H. and Finger, E. N. and Magliaro, B. C. and Smith, S. M. and Converso, A. and Sanderson, P. E. and Mullins, D. and Hyde, L. A. and others},
  title   = {{The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents}},
  journal = {Neuropharmacology},
  year    = {2011},
  doi     = {10.1016/j.neuropharm.2011.05.009},
  pmid    = {21619887},
  url     = {https://doi.org/10.1016/j.neuropharm.2011.05.009}
}

@article{pangalos2007-17599084,
  author  = {Pangalos, M. N. and Schechter, L. E. and Hurko, O.},
  title   = {{Drug development for CNS disorders: strategies for balancing risk and reducing attrition}},
  journal = {Nature reviews. Drug discovery},
  year    = {2007},
  doi     = {10.1038/nrd2094},
  pmid    = {17599084},
  url     = {https://doi.org/10.1038/nrd2094}
}

@article{moghaddam2012-21956446,
  author  = {Moghaddam, B. and Javitt, D.},
  title   = {{From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment}},
  journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
  year    = {2012},
  doi     = {10.1038/npp.2011.181},
  pmid    = {21956446},
  url     = {https://doi.org/10.1038/npp.2011.181}
}

@article{gotti1997-9364611,
  author  = {Gotti, C. and Fornasari, D. and Clementi, F.},
  title   = {{Human neuronal nicotinic receptors}},
  journal = {Progress in neurobiology},
  year    = {1997},
  doi     = {10.1016/s0301-0082(97)00034-8},
  pmid    = {9364611},
  url     = {https://doi.org/10.1016/s0301-0082(97)00034-8}
}

@article{koh2013-22732440,
  author  = {Koh, M. T. and Rosenzweig-Lipson, S. and Gallagher, M.},
  title   = {{Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment}},
  journal = {Neuropharmacology},
  year    = {2013},
  doi     = {10.1016/j.neuropharm.2012.06.023},
  pmid    = {22732440},
  url     = {https://doi.org/10.1016/j.neuropharm.2012.06.023}
}

@article{tahtouh2012-22998443,
  author  = {Tahtouh, T. and Elkins, J. M. and Filippakopoulos, P. and Soundararajan, M. and Burgy, G. and Durieu, E. and Cochet, C. and Schmid, R. S. and others},
  title   = {{Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B}},
  journal = {Journal of medicinal chemistry},
  year    = {2012},
  doi     = {10.1021/jm301034u},
  pmid    = {22998443},
  url     = {https://doi.org/10.1021/jm301034u}
}

@article{rissman2011-21388375,
  author  = {Rissman, R. A. and Mobley, W. C.},
  title   = {{Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease}},
  journal = {Journal of neurochemistry},
  year    = {2011},
  doi     = {10.1111/j.1471-4159.2011.07237.x},
  pmid    = {21388375},
  url     = {https://doi.org/10.1111/j.1471-4159.2011.07237.x}
}

@article{debdab2011-21615147,
  author  = {Debdab, M. and Carreaux, F. and Renault, S. and Soundararajan, M. and Fedorov, O. and Filippakopoulos, P. and Lozach, O. and Babault, L. and others},
  title   = {{Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing}},
  journal = {Journal of medicinal chemistry},
  year    = {2011},
  doi     = {10.1021/jm200274d},
  pmid    = {21615147},
  url     = {https://doi.org/10.1021/jm200274d}
}

@article{smith2012-23173067,
  author  = {Smith, B. and Medda, F. and Gokhale, V. and Dunckley, T. and Hulme, C.},
  title   = {{Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?}},
  journal = {ACS chemical neuroscience},
  year    = {2012},
  doi     = {10.1021/cn300094k},
  pmid    = {23173067},
  url     = {https://doi.org/10.1021/cn300094k}
}

@article{kornhuber1994-7884411,
  author  = {Kornhuber, Johannes and Weller, Michael and Schoppmeyer, K. and Riederer, P.},
  title   = {{Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties}},
  journal = {PubMed},
  year    = {1994},
  pmid    = {7884411}
}

@article{stoffelwagner2001-11720889,
  author  = {Stoffel‐Wagner, Birgit},
  title   = {{Neurosteroid metabolism in the human brain}},
  journal = {European Journal of Endocrinology},
  year    = {2001},
  doi     = {10.1530/eje.0.1450669},
  pmid    = {11720889},
  url     = {https://doi.org/10.1530/eje.0.1450669}
}

@article{rossor1986-2869818,
  author  = {Rossor, Martin N. and Iversen, L L},
  title   = {{NON-CHOLINERGIC NEUROTRANSMITTER ABNORMALITIES IN ALZHEIMER'S DISEASE}},
  journal = {British Medical Bulletin},
  year    = {1986},
  doi     = {10.1093/oxfordjournals.bmb.a072101},
  pmid    = {2869818},
  url     = {https://doi.org/10.1093/oxfordjournals.bmb.a072101}
}

@article{bowen1983-6306169,
  author  = {Bowen, David M. and Allen, Shelley Jane and Benton, J. S. and Goodhardt, Michèle and Haan, E and Palmer, Alan M. and Sims, Neil R. and Smith, Christopher and others},
  title   = {{Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease}},
  journal = {Journal of Neurochemistry},
  year    = {1983},
  doi     = {10.1111/j.1471-4159.1983.tb11838.x},
  pmid    = {6306169},
  url     = {https://doi.org/10.1111/j.1471-4159.1983.tb11838.x}
}

@article{kaur2026-c1b494a3,
  author  = {Kaur, B. and Abdo, A. N. and Cho, S. and Gabr, M. T.},
  title   = {{DNA-Encoded Library-Guided Discovery of a First-in-Class Molecular Glue of the NOS1AP-SCRIB Complex in Alzheimer’s Disease Patient-Derived Neurons}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.10.12.758423},
  url     = {https://doi.org/10.64898/2026.10.12.758423}
}

@article{ugur2026-bb2a526b,
  author  = {Ugur, S. and Onal Suzek, T.},
  title   = {{Integrated Transcriptomic and Structural Prioritization of Sulforaphane Targets in Neurodegeneration: A Multi-Dataset In Silico Study}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.10.20.760417},
  url     = {https://doi.org/10.64898/2026.10.20.760417}
}

@article{nago2026-f876eb5b,
  author  = {Nago, B. and Qu, C.},
  title   = {{Simulating the Effects of Gamma Oscillation Treatment on Selective Neurotransmitters Using The Virtual Brain and Complex Pathway Simulator}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-11199141/v2},
  url     = {https://doi.org/10.21203/rs.3.rs-11199141/v2}
}

@article{iftikhar2026-5f7606f8,
  author  = {Iftikhar, H. and Ejaz, M. M. and Al-Namshah, K. S. and Khan, S. and Ashraf, S. and Meer, N. and Riaz, M. and Saleem, M.},
  title   = {{Natural Sesquiterpenoids from Laggera pterodonta as bioactive Acetylcholinesterase Inhibitors: Insights from DFT, Molecular Docking, and ADMET Profiling}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-11218173/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-11218173/v1}
}

@article{ejaz2026-f06e02fb,
  author  = {Ejaz, M. M. and Iftikhar, H. and Al-Namshah, K. and Khan, S. and Ashraf, S. and Meer, N. and Riaz, M. and Saleem, M. and others},
  title   = {{Substituent Effects on Electronic Properties and Acetylcholinesterase Inhibitory Potential of Donepezil Analogues: A DFT, Molecular Docking, and ADMET Study with Dynamics Validation of the Lead Candidate}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-11082767/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-11082767/v1}
}

@article{dange2026-86ec91fb,
  author  = {Dange¹, R. T. and Jadhav², S. B. and RAj, rupali},
  title   = {{Docking-Guided Design and Biological Evaluation of a Lead Convolvine-Based Acetylcholinesterase Inhibitor for Alzheimer's Disease}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10890265/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10890265/v1}
}

@article{holtz2026-d33b0eda,
  author  = {Holtz, M. and de Haan, S. and Castellví Domingo, C. and Madsen, N. G. and Salazar, M. D. F. and Hansson, F. G. and van Aalst, A. C. A. and Arnesen, J. A. and others},
  title   = {{Biocatalytic Production of Galantamine in Yeast through Cytochrome P450 Optimization}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.09.09.750345},
  url     = {https://doi.org/10.64898/2026.09.09.750345}
}

@article{ban2026-0ffeafec,
  author  = {Ban, K. and Kajiwara, S. and Hashizume, T. and Ninomiya, M. and Koketsu, M.},
  title   = {{Structural optimization of coumarin-pyridine hybrid derivative salts as potent acetylcholinesterase inhibitors}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10583076/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10583076/v1}
}

@article{rautela2026-3e3bf661,
  author  = {Rautela, R. and Gupta, S. M. and Gaurav, A.},
  title   = {{Discovery of Natural Cholinesterase Inhibitors via Integrated Computational Studies using Labdane-Related Diterpenoids-based Pharmacophore Model and in-vitro studies}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10417596/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10417596/v1}
}

@article{rathi2026-2e030f13,
  author  = {Rathi, R.},
  title   = {{Computational Screening of FDA-Approved Drugs as Potential BACE1 Inhibitors for Alzheimer's Disease Drug Repurposing}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10465925/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10465925/v1}
}

@article{baral2026-e2e1ba0c,
  author  = {Baral, D. S. and Verma, R.},
  title   = {{Exploring the Molecular and Biochemical Mechanisms of Aromasin in Modulating COX-2/iNOS for Alzheimer’s Disease-Associated Synaptic Dysfunction: An In Silico Drug Repurposing Study}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10701602/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10701602/v1}
}

@article{rathi2026-5bb621f8,
  author  = {Rathi, R.},
  title   = {{Computational Screening of 1,348 FDA-Approved Drugs as Potential BACE1 Inhibitors for Alzheimer's Disease Drug Repurposing}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10484841/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10484841/v1}
}

@article{dasgupta2026-cfdd9ac7,
  author  = {Dasgupta, M. and Konar, A. and Nagar, A.},
  title   = {{Magnetic Field–Enhanced Docosahexaenoic Acid Delivery for Acetylcholine Restoration in Alzheimer’s Disease: an In Silico Study}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.09.28.755051},
  url     = {https://doi.org/10.64898/2026.09.28.755051}
}

@article{patil2026-039d6010,
  author  = {Patil, S. P. and Kuehn, B. and Schlosser, R. and Samohod, J.},
  title   = {{Discovery of Bavachin as a Dual Trk-A/Trk-B Agonist via Integrated Computational Screening and Experimental Validation}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.09.10.750759},
  url     = {https://doi.org/10.64898/2026.09.10.750759}
}

@article{shimbara2026-f6000fdf,
  author  = {Shimbara, K.},
  title   = {{Network Pharmacology and Molecular Docking Uncover Novel Candidate Compound-Target Actions of Yokukansan (Yi-Gan San) in the Behavioral and Psychological Symptoms of Dementia}},
  journal = {Preprints.org},
  year    = {2026},
  doi     = {10.20944/preprints202607.1493.v1},
  url     = {https://doi.org/10.20944/preprints202607.1493.v1}
}